Summary.-The method of measuring changes in the structuredness of cytoplasmic matrix (SCM) in single cells is described. Data on SCM distributions and fractions of human lymphocyte populations which respond to stimulations with PHA and CaBP in healthy donors and patients with malignant disorders are presented.
LYMPHOCYTES from patients with malignant diseases can be differentiated from those of healthy donors or donors with non-malignant disorders on the basis of changes in the structuredness of cytoplasmic matrix (SCM) induced by cancer basic protein (CaBP), tumour-tissue associated antigens and phytohaemagglutinin (PHA) (Cercek, Cercek and Garrett, 1 974b; Cercek, Cercek and Franklin, 1974a; Cercek and Cercek, 1975a, b) . Changes in the SCM are measured on cell suspensions with the technique of fluorescence polarization in a fluorescence spectrophotometer of high sensitivity (Cercek, Cercek and Ockey, 1973) . These measurements yield data on average changes in the SCM over whole cell populations, and cannot yield estimates of the percentages of cells which change their SCM on stimulation. We have, therefore, extended the technique of fluorescence polarization to measurements of changes in the SCM on single cells. This paper describes the SCM technique for single cells and presents data on SCM distributions and fractions of lymphocyte populations which respond to stimulations with CaBP and PHA in healthy donors and in patients with malignant disorders.
AIATERIALS AND METHODS
Preparation of lymphocytes.-Human lymphocytes were prepared from blood collected in Searle-LH/10 lithium heparin-containing vials. Lymphocytes in a pure state (>90%0) wAere obtained by the Ficoll-Triosil gradient separation (Harris and Ukaejiofo, 1969) . Details of these procedures were described before (Cercek et al., 1974b) . Lymphocytes were suspended in TC Medium 199 (Wellcome Ltd) at a concentration of approximately 6 x 106 cells/ml.
Stimulation of lymphocytes.-Aliquots of 0 5 ml of lymphocyte suspensions were incubated for 30 min at 37°C with either 0 05 ml of a 5 times diluted reagent-grade PHA (Wellcome Ltd) or 0 05 ml of partly purified CaBP solution. The concentration of CaBP was, on the basis of the dose response curve for the particular batch, adjusted to give a maximum response with respect to the number of lymphocytes. CaBP was a gift from Dr J. P. Dickinson, Cookridge Hospital, University Department of Radiotherapy, Leeds.
Preparation of FDA solutions.-Fluorescein diacetate (FDA) is practically insoluble in water. Aqueous solutions of FDA in complete phosphate buffered saline (PBS) (Paul, 1970) are, therefore, prepared by sequential dilution of a stock solution of 25 mg of recrystallized FDA/ml of Analar grade propanone or butan-2-on (Fluka Fluo-rochem Ltd). 0-02 ml of the FDA stock solution is first injected into 100 ml of sterile PBS. A slightly milky solution is obtained. This solution tends to flocculate and must, therefore, be immediately subdiluted by injecting 10 ml of this solution into 100 ml of sterile PBS, with a further dilution by injecting 20 ml into 50 ml of sterile PBS. This latter solution (0-31 ,uM FDA in PBS) is used in SCM measurements. We have noticed that recent batches of the organic solvents and FDA contain impurities which decrease the SCM of lymphocytes. However, the above sequential dilution decreases the impurities below the threshold level at which they would start to affect the lymphocytes and thus abrogate mitogenic or antigenic stimulations. The minimum proportion (F) of lymphocytes which must undergo a change of P in order to convert the control distribution into the treated distribution can be calculated as follows: 
Measurements

RESULTS
The control SCM values of individual lymphocytes in populations from 5 healthy donors and 7 patients with cancer range from P 0 10 to P 0 30 with mean values of P ranging from 0-188 to 0-221 (Table I) . Examples of distributions of P values within a population of lymphocytes from a healthy donor and a donor with cancer are shown as histograms in Fig. 1 Fig. 1 and in those from a cancer patient in Fig. 2 (Cercek and Cercek, 1975a; Cercek et al., 1974a) . The SCM values of individual lymphocytes in populations of unstimulated lymphocytes from healthy donors and from patients with cancer range from P 0aIO to P 0 30 ( Fig. 1 and 2) , with mean values of P between 0.188 and 0-221 (Table I) . This is in agreement with measurements on unstimulated lympho- cyte suspensions carried out in a fluorescence spectrophotometer which also showed that there are no differences between the unstimulated SCM values of healthy donors and patients with cancer (Cercek et al., 1974a Figs. 1 and 2 provide no evidence of bimodality in the value of P in stimulated lymphocytes. They do not therefore support the idea that the lymphocytes fall into two classes, responders and non-responders, in spite of our large estimates of F, " the responding fraction ".
It must be stressed that these estimates of F are minimal and are even compatible with a uniform shift downwards in the P values of all the lymphocytes.
The magnitude of the responses of single cells to stimulations by PHA and CaBP cannot be derived from the present results. To elucidate these points, further studies on SCM charrges of single lymphocytes are in progress.
In conclusion, this study has demonstrated the feasibility of SCM measurements on single cells. It offers not only an alternative to measurements of the SCM on cell suspensions in a fluorescence spectrophotometer (Cercek et al., 1973; 1974a, b) , but also information on the SCM distributions in cell populations and changes in the SCM within the population on stimulation or treatment with different agents.
